Purchase Order SPE2DP15M0358
Award Date 5/13/15
Potential Completion Date 5/26/15
Potential Value $771K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Walsh Healy Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $1,101,022 firm fixed-price purchase order was awarded by the Defense agency Medical Supply Chain to the pharmaceutical company Glaxosmithkline, LLC to provide hepatitis B virus vaccines. The award has an ultimate completion date of February 8, 2017 and was not set aside for any special category of contractor. Glaxosmithkline, which is a foreign-owned for-profit organization, has received numerous federal contracts and grants to supply vaccines, antiviral medications, and other...
- This federal contract award, valued at $1,853,610.00, was granted to GlaxoSmithKline, LLC for the delivery of inactivated hepatitis A vaccines. The contract was awarded by the Defense agency Medical Supply Chain. It is a firm fixed price purchase order with no set-aside designation. GlaxoSmithKline, a pharmaceutical company that provides vaccines and other medical products to various U.S. government agencies, has delivered these hepatitis A vaccines as part of their role as a prime contractor on...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services to Glaxosmithkline, LLC to provide influenza and hepatitis vaccines for government stockpiling efforts. The $107,362.72 contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). There was no set-aside designation for this order. Glaxosmithkline, a major pharmaceutical company, has been awarded multiple federal contracts and indefinite delivery vehicles to supply...
- This federal contract award is for vaccines and pharmaceutical products provided to the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration by GlaxoSmithKline, LLC. The contract has a potential value of $115,680.30, is a firm fixed price delivery order, and is not set aside for any specific business type. The contract was awarded on September 12, 2017, with a completion date of September 22, 2017. GlaxoSmithKline, a large pharmaceutical company, has...
- This is a firm fixed-price delivery order awarded to Glaxosmithkline, LLC by the Tennessee National Guard for $29,768.10 to provide hepatitis A and B vaccines. The order is not associated with a set-aside. The primary service location is in Durham, North Carolina. Glaxosmithkline is a pharmaceutical company that has experience providing a range of vaccines and antiviral medications to U.S. government agencies through federal contracts and grants, including to the Departments of Defense, Veterans...
- This is a firm fixed price BPA call contract awarded by the Immunization and Vaccine Agency, a division of the Department of Health and Human Services, to GlaxoSmithKline, LLC, a pharmaceutical company, for $87,583.16. The contract is for agency-wide requirements related to immunization and vaccine products, with no set-aside designation. GlaxoSmithKline has provided a range of pharmaceutical goods and services as the prime contractor on previous federal contracts, including influenza virus...
- This federal contract award was issued by the Office of the Assistant Secretary for Administration, a civilian agency, to GlaxoSmithKline, LLC, a pharmaceutical company, for the delivery of vaccines. The contract, which is not set-aside, has a ceiling value of $133,372.10 and is a firm fixed price delivery order under the GSA Pharmaceuticals and Drugs Schedule. The contract supports the government's vaccine stockpiling initiatives and provides influenza and hepatitis vaccines, COVID-19...
- This is a federal contract award from the U.S. Department of Health and Human Services to Glaxosmithkline, LLC, a pharmaceutical company, for the supply of vaccines. The contract has a ceiling value of $220,298.59 and is a firm fixed price delivery order placed against Glaxosmithkline's General Services Administration (GSA) Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs. The contract has no set-aside designation. The contract supports the government's vaccine stockpiling...
- The Department of Health and Human Services awarded a $121,391.84 firm fixed-price delivery order to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of vaccines. This award is part of a larger General Services Administration Federal Supply Schedule 61 contract for pharmaceuticals and drugs. The contract does not have a set-aside designation and the place of performance is Glaxosmithkline's facility in Research Triangle Park, North Carolina. Glaxosmithkline is a major supplier...
- This is a firm fixed-price delivery order awarded by the Department of Health and Human Services to GlaxoSmithKline, LLC, a pharmaceutical company, for the supply of a GlaxoSmithKline vaccine for stock. The contract has a ceiling value of $92,136 and a completion date of October 25, 2015. The contract is not set-aside and was issued under GlaxoSmithKline's General Services Administration (GSA) Schedule 61 contract for pharmaceuticals and drugs. GlaxoSmithKline has provided a range of...